During the past decade, Centro Clinico Mediterraneo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Clinico Mediterraneo" are "Primary Biliary Cholangitis" (1 trials) and "Primary Biliary Cirrhosis" (1 trials). Many other conditions were trialed in "Centro Clinico Mediterraneo" in a lesser frequency.

Most popular intervention types in "Centro Clinico Mediterraneo" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Seladelpar 10 mg" (1 trials), "Seladelpar 10 mg Capsule" (1 trials), "Seladelpar 5 mg" (1 trials) and "Seladelpar 5 mg Capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Clinico Mediterraneo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Clinico Mediterraneo". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro Clinico Mediterraneo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Clinico Mediterraneo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".